Operaciones Biomea Fusion, Inc. - BMEA CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Diferencial | 0.13 | ||||||||
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.025457% | ||||||||
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.003235% | ||||||||
Horario tarifa nocturna | 21:00 (UTC) | ||||||||
Cantidad comercializada mínima | 1 | ||||||||
Divisa | USD | ||||||||
Margen | 20% | ||||||||
Mercado de valores | United States of America | ||||||||
Comisión por operación | 0% |
*Information provided by Capital.com
Biomea Fusion Inc ESG Risk Ratings
‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.
Cierre previo* | 31.44 |
Abrir* | 31.13 |
Cambio de 1 año* | 503.29% |
Rango del día* | 30.62 - 32.32 |
Rango de 52 semanas | 4.41-36.68 |
Volumen medio (10 días) | 367.05K |
Volumen medio (3 meses) | 19.98M |
Capitalización de mercado | 1.11B |
Ratio P/E | -100.00K |
Acciones en circulación | 35.40M |
Ingresos | N/A |
EPS | -3.21 |
Dividendo (Rendimiento %) | N/A |
Beta | -100.00K |
Próxima fecha de resultados | N/A |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Cierre | Change | Change (%) | Apertura | High | Low |
---|---|---|---|---|---|---|
May 26, 2023 | 31.35 | 0.22 | 0.71% | 31.13 | 32.45 | 30.48 |
May 25, 2023 | 31.44 | -1.20 | -3.68% | 32.64 | 32.86 | 30.91 |
May 24, 2023 | 32.61 | 2.07 | 6.78% | 30.54 | 32.89 | 30.11 |
May 23, 2023 | 30.98 | -0.61 | -1.93% | 31.59 | 32.69 | 30.53 |
May 22, 2023 | 31.58 | -0.08 | -0.25% | 31.66 | 32.80 | 30.67 |
May 19, 2023 | 31.64 | -0.03 | -0.09% | 31.67 | 32.74 | 31.15 |
May 18, 2023 | 32.02 | -0.82 | -2.50% | 32.84 | 33.19 | 30.81 |
May 17, 2023 | 32.79 | 0.79 | 2.47% | 32.00 | 33.41 | 31.88 |
May 16, 2023 | 32.81 | -1.37 | -4.01% | 34.18 | 34.18 | 31.24 |
May 15, 2023 | 33.84 | -0.11 | -0.32% | 33.95 | 35.67 | 33.57 |
May 12, 2023 | 33.94 | 0.99 | 3.00% | 32.95 | 34.77 | 32.20 |
May 11, 2023 | 31.94 | -0.52 | -1.60% | 32.46 | 33.05 | 31.62 |
May 10, 2023 | 32.88 | -0.57 | -1.70% | 33.45 | 34.46 | 32.65 |
May 9, 2023 | 33.63 | 0.56 | 1.69% | 33.07 | 35.62 | 32.96 |
May 8, 2023 | 33.28 | 1.17 | 3.64% | 32.11 | 34.76 | 31.98 |
May 5, 2023 | 32.47 | 0.51 | 1.60% | 31.96 | 33.70 | 31.22 |
May 4, 2023 | 31.91 | 1.31 | 4.28% | 30.60 | 32.24 | 29.60 |
May 3, 2023 | 30.60 | 1.65 | 5.70% | 28.95 | 31.03 | 28.65 |
May 2, 2023 | 28.90 | -2.60 | -8.25% | 31.50 | 31.89 | 28.70 |
May 1, 2023 | 31.61 | 2.19 | 7.44% | 29.42 | 32.31 | 28.67 |
Biomea Fusion, Inc. Events
Hora (UTC) (UTC) | País | Evento |
---|---|---|
No events scheduled |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Ingresos totales | 0 | 0 | 0 | 0 |
Gastos totales de explotación | 83.634 | 41.667 | 5.327 | 1.195 |
Gastos de venta/general/administración Gastos, total | 20.921 | 13.671 | 1.656 | 0.103 |
Investigación y desarrollo | 62.713 | 27.996 | 3.671 | 1.092 |
Ingresos de explotación | -83.634 | -41.667 | -5.327 | -1.195 |
Ingresos por intereses (gastos), netos No operativos | 1.806 | 0.1 | 0.003 | -0.003 |
Ingresos netos antes de impuestos | -81.828 | -41.567 | -5.324 | -1.198 |
Ingresos netos después de impuestos | -81.828 | -41.567 | -5.324 | -1.198 |
Beneficio neto antes de partidas extra. Elementos | -81.828 | -41.567 | -5.324 | -1.198 |
Ingresos netos | -81.828 | -41.567 | -5.324 | -1.198 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -81.828 | -41.567 | -5.324 | -1.198 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -81.828 | -41.567 | -5.324 | -1.198 |
Beneficio neto diluido | -81.828 | -41.567 | -5.324 | -1.198 |
Promedio ponderado de acciones diluidas | 29.2718 | 23.8585 | 28.7679 | 28.7679 |
BPA diluido sin partidas extraordinarias | -2.79546 | -1.74223 | -0.18507 | -0.04164 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | ||
BPA normalizado diluido | -2.79546 | -1.74223 | -0.18507 | -0.04164 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Ingresos totales | 0 | 0 | 0 | 0 | 0 |
Gastos totales de explotación | 30.031 | 26.276 | 23.484 | 17.474 | 16.4 |
Gastos de venta/general/administración Gastos, total | 5.636 | 5.737 | 5.242 | 4.892 | 5.05 |
Investigación y desarrollo | 24.395 | 20.539 | 18.242 | 12.582 | 11.35 |
Ingresos de explotación | -30.031 | -26.276 | -23.484 | -17.474 | -16.4 |
Ingresos por intereses (gastos), netos No operativos | 0.98 | 0.962 | 0.594 | 0.216 | 0.034 |
Ingresos netos antes de impuestos | -29.051 | -25.314 | -22.89 | -17.258 | -16.366 |
Ingresos netos después de impuestos | -29.051 | -25.314 | -22.89 | -17.258 | -16.366 |
Beneficio neto antes de partidas extra. Elementos | -29.051 | -25.314 | -22.89 | -17.258 | -16.366 |
Ingresos netos | -29.051 | -25.314 | -22.89 | -17.258 | -16.366 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -29.051 | -25.314 | -22.89 | -17.258 | -16.366 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -29.051 | -25.314 | -22.89 | -17.258 | -16.366 |
Beneficio neto diluido | -29.051 | -25.314 | -22.89 | -17.258 | -16.366 |
Promedio ponderado de acciones diluidas | 29.5865 | 29.4435 | 29.319 | 29.1964 | 29.1261 |
BPA diluido sin partidas extraordinarias | -0.9819 | -0.85975 | -0.78072 | -0.5911 | -0.5619 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
BPA normalizado diluido | -0.9819 | -0.85975 | -0.78072 | -0.5911 | -0.5619 |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Total Activo Corriente | 117.819 | 176.561 | 62.223 | 0.265 |
Efectivo e inversiones a corto plazo | 113.049 | 173.516 | 61.695 | 0.239 |
Efectivo y Equivalentes | 111.899 | 145.736 | 61.695 | 0.239 |
Prepaid Expenses | 4.77 | 3.045 | 0.492 | 0.015 |
Other Current Assets, Total | 0.036 | 0.011 | ||
Total Assets | 129.307 | 185.705 | 62.526 | 0.265 |
Property/Plant/Equipment, Total - Net | 7.992 | 5.687 | 0.291 | 0 |
Property/Plant/Equipment, Total - Gross | 8.908 | 5.944 | 0.299 | 0 |
Accumulated Depreciation, Total | -0.916 | -0.257 | -0.008 | 0 |
Other Long Term Assets, Total | 3.496 | 1.581 | 0.012 | 0 |
Total Current Liabilities | 19.101 | 4.637 | 1.619 | 0.286 |
Accounts Payable | 6.826 | 1.329 | 0.727 | 0.271 |
Accrued Expenses | 11.639 | 2.828 | 0.856 | 0.015 |
Notes Payable/Short Term Debt | 0 | 0 | 0.036 | 0 |
Total Liabilities | 20.768 | 6.922 | 1.619 | 0.286 |
Total Long Term Debt | 0 | 0 | 0 | 0 |
Total Equity | 108.539 | 178.783 | 60.907 | -0.021 |
Preferred Stock - Non Redeemable, Net | 0 | 55.738 | 0 | |
Common Stock | 0.003 | 0.003 | 0.001 | 0.001 |
Additional Paid-In Capital | 240.107 | 228.532 | 13.343 | 2.829 |
Retained Earnings (Accumulated Deficit) | -131.57 | -49.742 | -8.175 | -2.851 |
Total Liabilities & Shareholders’ Equity | 129.307 | 185.705 | 62.526 | 0.265 |
Total Common Shares Outstanding | 29.5616 | 29.1156 | 28.7679 | 28.7679 |
Inversiones a corto plazo | 1.15 | 27.78 | ||
Long Term Investments | 0 | 1.876 | ||
Other Current Liabilities, Total | 0.636 | 0.48 | ||
Other Liabilities, Total | 1.667 | 2.285 | ||
Other Equity, Total | -0.001 | -0.01 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total Activo Corriente | 88.931 | 117.819 | 138.861 | 154.138 | 167.023 |
Efectivo e inversiones a corto plazo | 86.3 | 113.049 | 133.458 | 149.633 | 164.806 |
Efectivo y Equivalentes | 86.3 | 111.899 | 132.311 | 148.481 | 156.215 |
Inversiones a corto plazo | 0 | 1.15 | 1.147 | 1.152 | 8.591 |
Total deudores, neto | |||||
Accounts Receivable - Trade, Net | |||||
Prepaid Expenses | 2.631 | 4.77 | 5.403 | 4.505 | 2.217 |
Other Current Assets, Total | |||||
Total Assets | 112.638 | 129.307 | 145.05 | 161.736 | 174.864 |
Property/Plant/Equipment, Total - Net | 19.467 | 7.992 | 5.345 | 5.437 | 5.476 |
Property/Plant/Equipment, Total - Gross | 20.676 | 8.908 | 6.078 | 5.998 | 5.867 |
Accumulated Depreciation, Total | -1.209 | -0.916 | -0.733 | -0.561 | -0.391 |
Long Term Investments | 0 | 0.01 | 0.186 | 0.415 | |
Other Long Term Assets, Total | 4.24 | 3.496 | 0.834 | 1.975 | 1.95 |
Total Current Liabilities | 18.774 | 19.101 | 12.589 | 9.362 | 7.962 |
Accounts Payable | 5.329 | 6.826 | 1.592 | 2.41 | 2.524 |
Accrued Expenses | 13.02 | 11.639 | 10.569 | 6.503 | 4.964 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0.425 | 0.636 | 0.428 | 0.449 | 0.474 |
Total Liabilities | 29.509 | 20.768 | 14.415 | 11.346 | 10.099 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Equity | 83.129 | 108.539 | 130.635 | 150.39 | 164.765 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | ||
Common Stock | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 |
Additional Paid-In Capital | 243.747 | 240.107 | 236.901 | 233.77 | 230.893 |
Retained Earnings (Accumulated Deficit) | -160.621 | -131.57 | -106.256 | -83.366 | -66.108 |
Other Equity, Total | 0 | -0.001 | -0.013 | -0.017 | -0.023 |
Total Liabilities & Shareholders’ Equity | 112.638 | 129.307 | 145.05 | 161.736 | 174.864 |
Total Common Shares Outstanding | 29.6511 | 29.5616 | 29.3888 | 29.2801 | 29.1687 |
Other Liabilities, Total | 10.735 | 1.667 | 1.826 | 1.984 | 2.137 |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Ingresos netos/Línea de salida | -81.828 | -41.567 | -5.324 | -1.198 |
Efectivo de actividades de explotación | -62.417 | -35.438 | -4.459 | -1.279 |
Efectivo de actividades de explotación | 0.691 | 0.249 | 0.008 | 0 |
Partidas no monetarias | 11.051 | 7.454 | 0.446 | 0 |
Cambios en el capital circulante | 7.669 | -1.574 | 0.411 | -0.081 |
Efectivo de actividades de inversión | 27.341 | -33.355 | -0.051 | 0 |
Gastos de capital | -1.03 | -3.171 | -0.051 | 0 |
Efectivo procedente de actividades de financiación | 1.239 | 153.185 | 65.966 | 1.44 |
Emisión (retiro) de acciones, neto | 1.239 | 153.221 | 65.93 | 1.44 |
Emisión (amortización) de deuda, neta | 0 | -0.036 | 0.036 | 0 |
Variación neta de la tesorería | -33.837 | 84.392 | 61.456 | 0.161 |
Otras partidas de flujo de caja de inversión, total | 28.371 | -30.184 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -29.051 | -81.828 | -56.514 | -33.624 | -16.366 |
Cash From Operating Activities | -24.044 | -62.417 | -42.216 | -25.421 | -9.994 |
Cash From Operating Activities | 0.293 | 0.691 | 0.51 | 0.336 | 0.166 |
Non-Cash Items | 3.846 | 11.051 | 8.182 | 5.297 | 2.57 |
Changes in Working Capital | 0.868 | 7.669 | 5.606 | 2.57 | 3.636 |
Cash From Investing Activities | -1.756 | 27.341 | 28.042 | 27.817 | 20.442 |
Capital Expenditures | -2.906 | -1.03 | -0.318 | -0.368 | -0.095 |
Other Investing Cash Flow Items, Total | 1.15 | 28.371 | 28.36 | 28.185 | 20.537 |
Cash From Financing Activities | 0.201 | 1.239 | 0.749 | 0.349 | 0.031 |
Issuance (Retirement) of Stock, Net | 0.201 | 1.239 | 0.749 | 0.349 | 0.031 |
Issuance (Retirement) of Debt, Net | 0 | 0 | 0 | 0 | |
Net Change in Cash | -25.599 | -33.837 | -13.425 | 2.745 | 10.479 |
Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
---|---|---|---|---|---|---|
Fidelity Management & Research Company LLC | Investment Advisor | 14.1094 | 4994898 | 2321876 | 2023-04-28 | LOW |
A2A Pharmaceuticals Inc | Corporation | 10.2398 | 3625000 | -275000 | 2023-05-12 | LOW |
Cormorant Asset Management, LP | Hedge Fund | 10.0869 | 3570872 | 0 | 2023-04-03 | LOW |
Janus Henderson Investors | Investment Advisor/Hedge Fund | 8.8021 | 3116057 | 358949 | 2023-03-31 | LOW |
Butler (Thomas Andrew) | Individual Investor | 8.4014 | 2974197 | 480790 | 2023-04-03 | |
Baker Bros. Advisors LP | Hedge Fund | 5.9573 | 2108949 | 4390 | 2023-03-31 | LOW |
Erdtmann (Rainer M) | Individual Investor | 5.8304 | 2064030 | -480790 | 2023-04-03 | |
Adage Capital Management, L.P. | Hedge Fund | 4.896 | 1733251 | 1733251 | 2023-03-31 | LOW |
Rock Springs Capital Management LP | Hedge Fund | 3.6643 | 1297213 | 566367 | 2023-03-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.0772 | 1089348 | 228771 | 2023-03-31 | LOW |
Driehaus Capital Management, LLC | Investment Advisor/Hedge Fund | 2.3996 | 849492 | 463419 | 2023-03-31 | MED |
Aisling Capital Management LP | Investment Advisor/Hedge Fund | 2.2563 | 798757 | 0 | 2023-03-31 | LOW |
Polar Capital LLP | Investment Advisor/Hedge Fund | 1.6525 | 585000 | 85000 | 2023-03-31 | LOW |
Laurion Capital Management LP | Hedge Fund | 1.5661 | 554400 | 125000 | 2023-03-31 | HIGH |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 1.3608 | 481722 | 378662 | 2023-03-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.2907 | 456909 | 27473 | 2023-03-31 | LOW |
Woodline Partners LP | Hedge Fund | 0.9651 | 341673 | 341673 | 2023-03-31 | HIGH |
Perceptive Advisors LLC | Private Equity | 0.918 | 325000 | 325000 | 2023-03-31 | MED |
Millennium Management LLC | Hedge Fund | 0.8108 | 287031 | 155657 | 2023-03-31 | HIGH |
Susquehanna International Group, LLP | Investment Advisor | 0.7178 | 254106 | 169999 | 2023-03-31 | MED |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group530K+
Traders
87K+
Clientes activos mensualmente
$46M+
Volumen mensual de inversión
$31M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Biomea Fusion, Inc. Company profile
Sobre Biomea Fusion Inc
Biomea Fusion, Inc. es una empresa biofarmacéutica en fase preclínica. La empresa se centra en el descubrimiento, el desarrollo y la comercialización de fármacos irreversibles de moléculas pequeñas para tratar a pacientes con cánceres definidos genéticamente. La empresa ha construido la plataforma de descubrimiento FUSION System para avanzar en una línea de productos de pequeñas moléculas irreversibles candidatos. El principal candidato a producto de la empresa, el BMF-219, está diseñado para ser un inhibidor irreversible, potente y selectivo, biodisponible por vía oral, de la menina, un importante regulador transcripcional que desempeña un papel directo en la señalización oncogénica en múltiples tipos de cáncer. La empresa está desarrollando el BMF-219 para el tratamiento de tumores líquidos y sólidos que dependen de la menina, incluidas las leucemias que contienen la proteína de fusión de la leucemia de linaje mixto (MLL). La empresa también está avanzando en otros programas preclínicos irreversibles para el tratamiento de determinados tipos de cáncer.
El precio actual de la acción Biomea Fusion, Inc. en tiempo real es 31.38 USD. El gráfico de la acción permite a los inversores comprender mejor el rendimiento y el precio de la acción y tomar decisiones informadas al negociar acciones y CFD.
Descubra más acciones con gráficos, datos vitales y actualizaciones de precios en tiempo real: Collegium Pharmaceutical, OVH Groupe S.A., Steel Connect, New York Mortgage, GTX Inc y KDDI Corporation. Para obtener más información, consulte los perfiles de las empresas en Capital.com.
Industry: | Biotechnology & Medical Research (NEC) |
900 Middlefield Road
4Th Floor
REDWOOD CITY
CALIFORNIA 94063
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 530.000 traders de todo el mundo que eligen operar con Capital.com